logo
logo

Torl Bio Therapeutics announced it raised $158 Million in an initial filing from an offering of $158 Million

Torl Bio Therapeutics announced it raised $158 Million in an initial filing from an offering of $158 Million

04/17/24, 3:07 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgculver city
Money raised
$158 million
Industry
biopharma
therapeutics
pharmaceutical
biotechnology
health care

Company Info

Company
TORL BioTherapeutics
Location
culver city, california, united states
Additional Info
TORL BioTherapeutics is building a preeminent biopharmaceutical company dedicated to the discovery, development, and commercialization of antibody-based therapies to improve and extend the lives of people with cancer worldwide. Through a strategic partnership with the Slamon Research Lab at UCLA, TORL has exclusive development and commercial rights to a large program of biologics-based drugs for promising, and novel cancer targets.

Related People